Skip to main content
Top
Published in: Tumor Biology 3/2016

01-03-2016 | Original Article

ROCK inhibitor Y-27632 inhibits the growth, migration, and invasion of Tca8113 and CAL-27 cells in tongue squamous cell carcinoma

Authors: Zhi-Ming Wang, Dong-Sheng Yang, Jie Liu, Hong-Bo Liu, Ming Ye, Yu-Fei Zhang

Published in: Tumor Biology | Issue 3/2016

Login to get access

Abstract

The objective of this study is to determine the effects of Rho-associated coiled-coil containing protein kinase (ROCK) inhibitor Y-27632 on the growth, invasion, and migration of Tca8113 and CAL-27 cells in tongue squamous cell carcinoma (TSCC). The methods of the study are as follows: After being routinely cultured for 24 h, Tca8113 and CAL-27 cells were treated with Y-27632 solution. The morphological change of Y-27632-treated cells was observed under an optical microscope and an inverted microscope; MTT assay was performed to measure the optical density (OD) of cells and calculate cell growth inhibition rate; the change of apoptosis was detected by AnnexinV-FITC/PI assay; cell invasion and migration were measured by Transwell assay. The results were as follows: (1) With increasing concentration of Y-27632, cell morphology changed and cell apoptosis appeared; (2) MTT assay showed that inhibition effect of Y-27632 on Tca8113 and CAL-27 cells was enhanced with increasing concentrations and time (all P < 0.01); (3) Apoptosis showed that, compared with controls, the number of apoptosis cells in experimental groups was significantly increased (all P < 0.01). Apoptosis rate was elevated with increasing concentrations of Y-27632; (4) Transwell assay showed, after a treatment with Y-27632, the number of migrated and invaded Tca8113 and CAL-27 cells in each group was statistically different (all P < 0.01); compared with controls, the number of migrated cell in groups treated with Y-27632 was decreased and less Tca8113 and CAL-27 cells in experimental groups passed through polycarbonate membrane (all P < 0.05). The study concludes that Y-27632 can inhibit the growth, invasion, and migration of Tca8113 and CAL-27 cells, suggesting that Y-27632 may be therapeutically useful in TSCC.
Literature
1.
go back to reference Eslami A, Miyaguchi K, Mogushi K, Watanabe H, Okada N, Shibuya H, et al. Parvb overexpression increases cell migration capability and defines high risk for endophytic growth and metastasis in tongue squamous cell carcinoma. Br J Cancer. 2015;112(2):338–44.CrossRefPubMed Eslami A, Miyaguchi K, Mogushi K, Watanabe H, Okada N, Shibuya H, et al. Parvb overexpression increases cell migration capability and defines high risk for endophytic growth and metastasis in tongue squamous cell carcinoma. Br J Cancer. 2015;112(2):338–44.CrossRefPubMed
2.
go back to reference Ding X, Zhang N, Cai Y, Li S, Zheng C, Jin Y, et al. Down-regulation of tumor suppressor mtus1/atip is associated with enhanced proliferation, poor differentiation and poor prognosis in oral tongue squamous cell carcinoma. Mol Oncol. 2012;6(1):73–80.CrossRefPubMed Ding X, Zhang N, Cai Y, Li S, Zheng C, Jin Y, et al. Down-regulation of tumor suppressor mtus1/atip is associated with enhanced proliferation, poor differentiation and poor prognosis in oral tongue squamous cell carcinoma. Mol Oncol. 2012;6(1):73–80.CrossRefPubMed
3.
go back to reference Makinen LK, Atula T, Hayry V, Jouhi L, Datta N, Lehtonen S, et al. Predictive role of toll-like receptors 2, 4, and 9 in oral tongue squamous cell carcinoma. Oral Oncol. 2015;51(1):96–102.CrossRefPubMed Makinen LK, Atula T, Hayry V, Jouhi L, Datta N, Lehtonen S, et al. Predictive role of toll-like receptors 2, 4, and 9 in oral tongue squamous cell carcinoma. Oral Oncol. 2015;51(1):96–102.CrossRefPubMed
4.
go back to reference Wang J, Liu XH, Yang ZJ, Xie B, Zhong YS. The effect of ROCK-1 activity change on the adhesive and invasive ability of y79 retinoblastoma cells. BMC Cancer. 2014;14:89.CrossRefPubMedPubMedCentral Wang J, Liu XH, Yang ZJ, Xie B, Zhong YS. The effect of ROCK-1 activity change on the adhesive and invasive ability of y79 retinoblastoma cells. BMC Cancer. 2014;14:89.CrossRefPubMedPubMedCentral
5.
go back to reference Narumiya S, Tanji M, Ishizaki T. Rho signaling, ROCK and mdia1, in transformation, metastasis and invasion. Cancer Metastasis Rev. 2009;28(1-2):65–76.CrossRefPubMed Narumiya S, Tanji M, Ishizaki T. Rho signaling, ROCK and mdia1, in transformation, metastasis and invasion. Cancer Metastasis Rev. 2009;28(1-2):65–76.CrossRefPubMed
6.
7.
go back to reference Wong CC, Wong CM, Tung EK, Man K, Ng IO. Rho-kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion. Hepatology. 2009;49(5):1583–94.CrossRefPubMed Wong CC, Wong CM, Tung EK, Man K, Ng IO. Rho-kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion. Hepatology. 2009;49(5):1583–94.CrossRefPubMed
8.
go back to reference Jiang L, Liu X, Kolokythas A, Yu J, Wang A, Heidbreder CE, et al. Downregulation of the Rho gtpase signaling pathway is involved in the microRNA-138-mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma. Int J Cancer. 2010;127(3):505–12.CrossRefPubMedPubMedCentral Jiang L, Liu X, Kolokythas A, Yu J, Wang A, Heidbreder CE, et al. Downregulation of the Rho gtpase signaling pathway is involved in the microRNA-138-mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma. Int J Cancer. 2010;127(3):505–12.CrossRefPubMedPubMedCentral
9.
go back to reference Vigil D, Kim TY, Plachco A, Garton AJ, Castaldo L, Pachter JA, et al. ROCK1 and ROCK2 are required for non-small cell lung cancer anchorage-independent growth and invasion. Cancer Res. 2012;72(20):5338–47.CrossRefPubMed Vigil D, Kim TY, Plachco A, Garton AJ, Castaldo L, Pachter JA, et al. ROCK1 and ROCK2 are required for non-small cell lung cancer anchorage-independent growth and invasion. Cancer Res. 2012;72(20):5338–47.CrossRefPubMed
10.
go back to reference Ohta T, Takahashi T, Shibuya T, Amita M, Henmi N, Takahashi K, et al. Inhibition of the Rho/ROCK pathway enhances the efficacy of cisplatin through the blockage of hypoxia-inducible factor-1alpha in human ovarian cancer cells. Cancer Biol Ther. 2012;13(1):25–33.CrossRefPubMed Ohta T, Takahashi T, Shibuya T, Amita M, Henmi N, Takahashi K, et al. Inhibition of the Rho/ROCK pathway enhances the efficacy of cisplatin through the blockage of hypoxia-inducible factor-1alpha in human ovarian cancer cells. Cancer Biol Ther. 2012;13(1):25–33.CrossRefPubMed
11.
go back to reference Guo Y, Liu Q, Yang Y, Guo X, Lian R, Li S, et al. The effects of ROCK inhibitor y-27632 on injectable spheroids of bovine corneal endothelial cells. Cell Reprogram. 2015;17(1):77–87.CrossRefPubMedPubMedCentral Guo Y, Liu Q, Yang Y, Guo X, Lian R, Li S, et al. The effects of ROCK inhibitor y-27632 on injectable spheroids of bovine corneal endothelial cells. Cell Reprogram. 2015;17(1):77–87.CrossRefPubMedPubMedCentral
12.
go back to reference Bueno C, Montes R, Menendez P. The ROCK inhibitor Y-27632 negatively affects the expansion/survival of both fresh and cryopreserved cord blood-derived cd34+ hematopoietic progenitor cells: Y-27632 negatively affects the expansion/survival of cd34 + hspcs. Stem Cell Rev. 2010;6(2):215–23.CrossRefPubMed Bueno C, Montes R, Menendez P. The ROCK inhibitor Y-27632 negatively affects the expansion/survival of both fresh and cryopreserved cord blood-derived cd34+ hematopoietic progenitor cells: Y-27632 negatively affects the expansion/survival of cd34 + hspcs. Stem Cell Rev. 2010;6(2):215–23.CrossRefPubMed
13.
go back to reference Zhang J, He X, Ma Y, Liu Y, Shi H, Guo W, et al. Overexpression of ROCK1 and ROCK2 inhibits human laryngeal squamous cell carcinoma. Int J Clin Exp Pathol. 2015;8(1):244–51.PubMedPubMedCentral Zhang J, He X, Ma Y, Liu Y, Shi H, Guo W, et al. Overexpression of ROCK1 and ROCK2 inhibits human laryngeal squamous cell carcinoma. Int J Clin Exp Pathol. 2015;8(1):244–51.PubMedPubMedCentral
14.
go back to reference Nakamura K, Yoshimura A, Kaneko T, Sato K, Hara Y. ROCK inhibitor y-27632 maintains the proliferation of confluent human mesenchymal stem cells. J Periodontal Res. 2014;49(3):363–70.CrossRefPubMed Nakamura K, Yoshimura A, Kaneko T, Sato K, Hara Y. ROCK inhibitor y-27632 maintains the proliferation of confluent human mesenchymal stem cells. J Periodontal Res. 2014;49(3):363–70.CrossRefPubMed
15.
go back to reference Abdel-Magid AF. Rho kinase inhibitors: potentially versatile therapy for the treatment of cardiovascular diseases and more. ACS Med Chem Lett. 2015;6(4):371–2.CrossRefPubMedPubMedCentral Abdel-Magid AF. Rho kinase inhibitors: potentially versatile therapy for the treatment of cardiovascular diseases and more. ACS Med Chem Lett. 2015;6(4):371–2.CrossRefPubMedPubMedCentral
16.
go back to reference Xu XT, Song QB, Yao Y, Ruan P, Tao ZZ. Inhibition of RhoA/ROCK signaling pathway promotes the apoptosis of gastric cancer cells. Hepatogastroenterology. 2012;59(120):2523–6.PubMed Xu XT, Song QB, Yao Y, Ruan P, Tao ZZ. Inhibition of RhoA/ROCK signaling pathway promotes the apoptosis of gastric cancer cells. Hepatogastroenterology. 2012;59(120):2523–6.PubMed
17.
go back to reference Wang L, Xue L, Yan H, Li J, Lu Y. Effects of ROCK inhibitor, y-27632, on adhesion and mobility in esophageal squamous cell cancer cells. Mol Biol Rep. 2010;37(4):1971–7.CrossRefPubMed Wang L, Xue L, Yan H, Li J, Lu Y. Effects of ROCK inhibitor, y-27632, on adhesion and mobility in esophageal squamous cell cancer cells. Mol Biol Rep. 2010;37(4):1971–7.CrossRefPubMed
18.
go back to reference Coleman ML, Densham RM, Croft DR, Olson MF. Stability of p21waf1/cip1 cdk inhibitor protein is responsive to RhoA-mediated regulation of the actin cytoskeleton. Oncogene. 2006;25(19):2708–16.CrossRefPubMed Coleman ML, Densham RM, Croft DR, Olson MF. Stability of p21waf1/cip1 cdk inhibitor protein is responsive to RhoA-mediated regulation of the actin cytoskeleton. Oncogene. 2006;25(19):2708–16.CrossRefPubMed
19.
go back to reference Ishizaki T, Uehata M, Tamechika I, Keel J, Nonomura K, Maekawa M, et al. Pharmacological properties of y-27632, a specific inhibitor of Rho-associated kinases. Mol Pharmacol. 2000;57(5):976–83.PubMed Ishizaki T, Uehata M, Tamechika I, Keel J, Nonomura K, Maekawa M, et al. Pharmacological properties of y-27632, a specific inhibitor of Rho-associated kinases. Mol Pharmacol. 2000;57(5):976–83.PubMed
20.
go back to reference Yang X, Di J, Zhang Y, Zhang S, Lu J, Liu J, et al. The Rho-kinase inhibitor inhibits proliferation and metastasis of small cell lung cancer. Biomed Pharmacother. 2012;66(3):221–7.CrossRefPubMed Yang X, Di J, Zhang Y, Zhang S, Lu J, Liu J, et al. The Rho-kinase inhibitor inhibits proliferation and metastasis of small cell lung cancer. Biomed Pharmacother. 2012;66(3):221–7.CrossRefPubMed
21.
go back to reference Schofield AV, Steel R, Bernard O. Rho-associated coiled-coil kinase (ROCK) protein controls microtubule dynamics in a novel signaling pathway that regulates cell migration. J Biol Chem. 2012;287(52):43620–9.CrossRefPubMedPubMedCentral Schofield AV, Steel R, Bernard O. Rho-associated coiled-coil kinase (ROCK) protein controls microtubule dynamics in a novel signaling pathway that regulates cell migration. J Biol Chem. 2012;287(52):43620–9.CrossRefPubMedPubMedCentral
22.
go back to reference Jeong KJ, Park SY, Cho KH, Sohn JS, Lee J, Kim YK, et al. The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion. Oncogene. 2012;31(39):4279–89.CrossRefPubMed Jeong KJ, Park SY, Cho KH, Sohn JS, Lee J, Kim YK, et al. The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion. Oncogene. 2012;31(39):4279–89.CrossRefPubMed
23.
go back to reference Wyckoff JB, Pinner SE, Gschmeissner S, Condeelis JS, Sahai E. ROCK- and myosin-dependent matrix deformation enables protease-independent tumor-cell invasion in vivo. Curr Biol. 2006;16(15):1515–23.CrossRefPubMed Wyckoff JB, Pinner SE, Gschmeissner S, Condeelis JS, Sahai E. ROCK- and myosin-dependent matrix deformation enables protease-independent tumor-cell invasion in vivo. Curr Biol. 2006;16(15):1515–23.CrossRefPubMed
Metadata
Title
ROCK inhibitor Y-27632 inhibits the growth, migration, and invasion of Tca8113 and CAL-27 cells in tongue squamous cell carcinoma
Authors
Zhi-Ming Wang
Dong-Sheng Yang
Jie Liu
Hong-Bo Liu
Ming Ye
Yu-Fei Zhang
Publication date
01-03-2016
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 3/2016
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-4115-6

Other articles of this Issue 3/2016

Tumor Biology 3/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine